Precision medicine is an innovative approach that allows doctors and healthcare providers to select specific treatments for a patient based on their individual genetic, protein, and lifestyle factors. This tailors treatments to an individual's needs rather than generic disease classifications. Precision medicine utilizes genomic analysis techniques, data science and other advanced technologies to develop personalized treatment and prevention strategies for diseases like cancer, diabetes and other conditions.
The global Precision Medicine Market is estimated to be valued at US$ 236.02 Mn in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growth of the precision medicine market size is majorly driven by the increasing adoption of precision medicine in emerging economies like India, China and Brazil. This is attributed to growing awareness about precision medicine and increasing investments made by market players to establish their manufacturing and R&D facilities in these regions. Moreover, extensive genomic and proteomic research conducted in emerging nations has generated huge amount of genetic data which aids in development of personalized treatment approaches specific to the population of that region. Large patient pool and low-cost clinical trials have further attracted established players to invest more in precision medicine sector of developing countries, thereby accelerating the market growth.
Segment Analysis
The global precision medicine market is dominated by the oncology segment. Cancer accounts for nearly one in six deaths worldwide, as per the World Health Organization. Precision medicine is increasingly being used for personalized cancer treatment. Through techniques like companion diagnostics and genomic profiling, precision medicine helps identify specific therapies or drug combinations best suited for an individual's tumor profile. This results in better treatment outcomes and quality of life for cancer patients.
Key Takeaways
The global precision medicine market is expected to witness high growth over the forecast period. Rapid advancements in genomics, big data analytics, and bioinformatics are enabling deeper characterization of diseases at the molecular level and powering precision medicine approaches. This is anticipated to augment market expansion. The global Precision Medicine Market is estimated to be valued at US$ 236.02 Mn in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030.
Regional analysis comprises
North America currently dominates the precision medicine market owing to sizeable research funding, advanced molecular diagnostic capabilities, and supportive regulatory environment. However, Asia Pacific is emerging as the fastest growing regional market with countries like China and India significantly ramping up investments in precision medicine R&D and genomic profiling capabilities. Government initiatives are also promoting the implementation of precision medicine strategies for improved healthcare outcomes.
Key players related content comprises
Key players operating in the precision medicine market are C L Pharm, Cure Pharmaceutical, Sunovion Pharmaceuticals Inc., ZIM Laboratories Limited, NAL Pharma, Viatris, LTS Lohmann Therapie-Systeme AG, IntelGenx Corp., and Aquestive Therapeutics Inc., among others. C L Pharm and Cure Pharmaceutical have a strong foothold in the oncology segment with their portfolio of companion diagnostics and personalized cancer medicines. Meanwhile, Sunovion Pharmaceuticals and ZIM Laboratories are expanding their precision therapeutics offerings for respiratory and cardiovascular indications.
Get more insights on this topic: https://www.newsstatix.com/precision-medicine-market-share-and-opportunity-analysis/
Explore more information, Please visit: https://allmeaninginhindi.com/aerial-imaging-capturing-new-perspectives-from-above/
Comments
0 comment